BVA.SI
Strong BuyPremium GrowerAI neutralTop Glove Corporation Bhd. · Healthcare · Malaysia · $1.6B
SGD 0.275 +14.6% · close 6 Oct · scored 7 Oct
StockRank up 9.7 since 6 Oct: Momentum up 13 after a 15% price rise.
Premium Grower: Strong business with the market behind it, priced at a premium.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Top Glove is the world's largest rubber glove maker, now recovering from the post-pandemic collapse in glove prices and utilisation. Recent momentum reflects improving volumes and a better US pricing environment as tariffs weigh on Chinese competitors. Gloves remain a largely commoditised product, with returns set by industry capacity, latex and nitrile input costs and energy prices rather than by pricing power.
ABOUT TOP GLOVE CORPORATION BHD.
Read
Top Glove Corporation Bhd. is the world's largest manufacturer of gloves, producing a wide range of natural rubber and synthetic gloves for healthcare and non-healthcare sectors. It holds a dominant global market share in glove manufacturing, benefiting from massive production capacity, economies of scale, and efficient operations. Top Glove is a critical supplier to the global healthcare industry, known for its continuous expansion and automation efforts.
FINANCIAL SUMMARY (SGD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.7B | 706.5M | 787.0M | 1.1B | -14.4% | 1.2B | 1.3B | 1.4B | 12.6% |
| EPS (SGD) | — | 0.01 | -0.04 | -0.00 | 0.00 | -22.6% | 0.01 | — | — | — |
| Shares | 8.0B | 8.0B | 8.0B | 8.0B | — | +0.1% | 8.0B | — | — | — |
| Debt | 151.0M | 130.5M | 182.1M | 132.1M | — | -4.4% | 269.9M | — | — | — |
| Equity | — | 2.1B | 1.8B | 1.8B | 1.5B | -11.1% | — | — | — | — |
| Op CF | — | 54.8M | 37.9M | 6.5M | 94.1M | 19.7% | 152.7M | — | — | — |
| Inv CF | — | 42.6M | -120.0M | 77.5M | 142.0M | — | — | — | — | — |
| Fin CF | — | -231.7M | 29.7M | -56.9M | -251.1M | — | — | — | — | — |
Swung more than 67% of stocks we rank over the past year (53% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BVA.SI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BVA.SI | Top Glove Corporation Bhd.(you) | $1.6B | 89 | Strong Buy |
| 7153.KL | Kossan Rubber Industries Bhd | $761M | 98 | Strong Buy |
| 7106.KL | Supermax Corporation Berhad | $319M | 57 | Hold |
| 0157.KL | Focus Point Holdings Berhad | $76M | 99 | Strong Buy |
| 0303.KL | Alpha IVF Group Berhad | $285M | 89 | Strong Buy |
| 7148.KL | Duopharma Biotech Berhad | $274M | 92 | Strong Buy |
| 5878.KL | KPJ Healthcare Berhad | $2.9B | 60 | Hold |
| 7081.KL | Pharmaniaga Berhad | $344M | 64 | Hold |
| 0101.KL | TMC Life Sciences Berhad | $186M | 73 | Buy |
| 0222.KL | Optimax Holdings Berhad | $67M | 85 | Strong Buy |
Peer medians: ROE 11.4% · P/E 23.1x · Gross margin 37.9%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.